HIV/AIDS in Africa
South Africa has the highest burden of HIV/AIDS in the world, with 5.6 million people living with the virus and over 400,000 newly infected annually. Since 2004, the U.S. government has committed more than $4 billion to combating HIV/AIDS in South Africa—the largest U.S. investment in HIV/AIDS worldwide. Continued progress in controlling HIV/AIDS in South Africa, the epicenter of the pandemic, is pivotal to sustained progress against the disease worldwide.
Three countries in Southern Africa have the highest adult HIV prevalence in the world: Swaziland (25.9%), Botswana (24.8%), and Lesotho (23.6%). Fiscal policy is crucial for addressing this HIV/AIDS crisis. Utilizing a calibrated model, this paper investigates the impact of fiscal policy on reducing the HIV/AIDS incidence rates in these countries. In particular, we studied the welfare impact of different taxation and debt paths in these countries in reducing the HIV/AIDS prevalence rates. This is particularly important given the current concerns about dwindling foreign aid (especially the global AIDS fund), and the fiscal deterioration and sustainability in these countries.
Evidence from Participatory Research on Community Health Systems for HIV treatment and support in East and southern Africa
The Community based systems in HIV treatment (CoBaSys) programme aims to understand and support conditions for community empowerment in services providing treatment for people living with HIV in east and southern Africa (ESA). A community system for health is understood to be the sum of the organizations, local government structures, civil society organizations, institutions and resources whose primary purpose is to improve health at community and primary care level.
The Survey is used to estimate the national prevalence of HIV and Syphilis infection among pregnant women and then establish HIV prevalence estimate among the adult population of 15-49 year olds. The study also determines the geographical distribution pattern of HIV and Syphilis infection among pregnant women attending antenatal clinics at national and provincial level by both district and age groups.